Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $264.6 million versus the consensus estimate of $263.77 million.

GUIDANCE:

Evolent Health sees Q4 2020 revenue of $249-264 million, versus the consensus of $266.6 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.